63
3
25
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T35827 |
Epsilon-V1-2
PKCε Inhibitor Peptide,Protein Kinase Cɛ Inhibitor Peptide,ɛV1-2 |
||
Protein kinase C (PKC ) is a calcium-independent, phospholipid- and diacylglycerol-dependent serine/threonine kinase involved in diverse signaling pathways, including those involved in neuronal signaling, cytoskeletal function, and inflammation.[1] PKC inhibitor peptide is a synthetic peptide corresponding to an amino acid sequence found in the amino terminal C2 domain of most mammalian forms of PKC .[2] It selectively and reversibly inhibits the translocation of PKC to intracellular membrane... | |||
T124032 |
V1 iridoid
|
||
V1 iridoid 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T124032。 | |||
T80249 |
Epsilon-V1-2, Cys-conjugated
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
Epsilon-V1-2, Cys-conjugated 是 εPKC 特异性抑制剂,通过阻断 εPKC 与 εRACK 锚定蛋白之间的相互作用,抑制 εPKC 易位及 MARCKS 磷酸化,从而表现生物活性。该肽将半胱氨酸残基接到 C 末端,以形成与载体蛋白的 SS 键。当序列 N 末端为谷氨酰胺 (Q) 或谷氨酸 (E) 时,肽可自发生成焦谷氨酰 (pGlu)。Q或E到pGlu的转化属于自然过程,并且pGlu的疏水性γ-内酰胺环对提高肽对胃肠道蛋白酶的稳定性起关键作用。在 HPLC 分析中,焦谷氨酰肽作为肽纯度的一部分进行检测,视为这类肽的典型子集。 | |||
T13920L |
Terlipressin Acetate
Terlipressin diacetate anhydrous,Terlipressin acetate anhydrous,醋酸特利加压素 |
Vasopressin Receptor | GPCR/G Protein |
Terlipressin Acetate 是一种高度选择性的加压素 V1 受体激动剂,对氧和葡萄糖剥夺/再氧合 (OGD/R) 诱导的肠上皮细胞损伤 (IEC-6) 具有抗炎和抗氧化作用,可用于肝肾综合征和耐去甲肾上腺素的败血性休克的研究。 | |||
T27503 |
GV150013
GV 150013,GV-150013 |
cholecystokinin | GPCR/G Protein |
GV150013是一种 cholecystokinin-2 (CCK2)受体拮抗剂。 | |||
T16163 |
MV1
|
Apoptosis | Apoptosis |
MV1 是一种 IAP 拮抗剂。 当与 HaloTag 配体结合时,它会导致 HaloTag 融合蛋白的蛋白质敲低。 | |||
T77693 |
Nav1.8-IN-4
|
Sodium Channel | Membrane transporter/Ion channel |
Nav1.8-IN-4 是一种有效的 Nav1.8 通道抑制剂,具有潜在的镇痛活性。Nav1.8-IN-4 可用于疼痛和神经系统相关疾病。 | |||
T16967 |
T-00127_HEV1
|
PI4K | PI3K/Akt/mTOR signaling |
T-00127_HEV1 是有效的phosphatidylinositol 4-kinase III beta 抑制剂,IC50为 60 nM。 | |||
T40508L |
TRV120056 acetate
TRV120056 acetate (40678-47-5 Free base) |
Others | Others |
TRV120056 acetate 是一种 Gq 偏向激动剂,对 AT1R-Gq 融合蛋白的分子效率比 AT1R-βarr2 融合蛋白高 10 倍。 | |||
T72170 |
NaV1.2/1.6 channel blocker-1
|
Sodium Channel | Membrane transporter/Ion channel |
NaV1.2/1.6 channel blocker-1 是一种有效的 NaV1.2/1.6 channel 阻滞剂,对 rNaV1.6 和 hNaV1.2 有抑制作用。NaV1.2/1.6 channel blocker-1 可用于研究全身性癫痫和运动障碍。 | |||
T12181 |
NaV1.7 inhibitor-1
|
Sodium Channel | Membrane transporter/Ion channel |
NaV1.7 inhibitor-1 是有效的、选择性的电压门控钠通道 (Nav) 1.7 抑制剂,对于hNaV1.7的IC50为 0.6 nM,其选择性是 hNaV1.5 的 80 倍。 | |||
T8579 |
Nav1.8-IN-1
5-(4-Chlorophenyl)-N-[[2-(2,2,2-trifluoroethoxy)pyridin-3-yl]methyl]pyridine-3-carboxamide,CHEMBL1270208 |
Sodium Channel | Membrane transporter/Ion channel |
Nav1.8-IN-1 (CHEMBL1270208) 是一种有效的 Na(v)1.8 钠通道抑制剂,可用于研究精神性疼痛及炎症性疼痛。 | |||
TP1554L |
HPV16 E7 (86-93) acetate
HPV16 E7 (86-93) acetate(160212-93-1 Free base) |
Others | Others |
HPV16 E7 (86-93) acetate 是人源白细胞抗原 A2.1 限制性 HPV16 E7 的衍生肽,在宫颈癌中具有免疫原性。 | |||
T60016 |
VV116
GS-621763-d1,JT001 |
SARS-CoV; RSV | Microbiology/Virology |
VV116 (JT001) 是一种针对呼吸道合胞病毒和 SARS-CoV-2 感染的选择性和口服活性核苷抗病毒剂。 | |||
T70362 | V11294A | ||
V11294A is a novel PDE4 inhibitor. A single oral 300 mg dose of V11294A administered to healthy volunteers results in plasma concentrations adequate to inhibit activation of inflammatory cells ex vivo, which persists for at least 24 h without any adverse reactions | |||
T83701 |
TRPV1-Tat TFA
Transient Receptor Potential Vanilloid 1-Tat,736-745-Tat |
||
TRPV1-Tat是一种针对瞬时受体电位范烤苷1 (TRPV1) 的肽类拮抗剂。它由来自TRPV1的A-激酶锚蛋白(AKAP)结合域的736-745个氨基酸以及来自HIV Tat的细胞穿透肽序列组成。TRPV1-Tat (200 µM) 能够在使用初级小鼠背根神经节的整细胞膜片钳技术中抑制由热或棕榈酸酯12-肉豆蔻酸13-醋酸酯(PMA014)引起的电流。当以10或30 µM剂量给药时,它能增加大鼠后爪机械痛阈。 | |||
T61110 | UC-1V150 | ||
UC-1V150 is a distinct TLR7 agonist, which activates cellular immune responses and exhibits anti-tumor effects. It also serves as a precursor for the synthesis of ISAC molecules, known as immune-stimulating antibody conjugates [1] [2]. | |||
T39995 |
TRV120055
TRV120055 |
||
TRV120055, a Gq-biased agonist, demonstrates a 10-fold higher molecular efficacy when tested against the AT1R-Gq fusion protein in comparison to the AT1R-βarr2 fusion protein. | |||
T19696 |
CV1808
CV 1808,CV-1808 |
||
CV-1808 is a coronary vasodilator, antihypertensive, and antipsychotic following systemic administration in vivo. CV-1808 is an adenosine A2 receptor agonist. | |||
T126501 |
Xanthone V1a
|
||
Xanthone V1a 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T126501。 | |||
T12180 |
Nav1.7-IN-6
|
Others | Others |
Nav1.7-IN-6, a selective inhibitor of Nav1.7. | |||
T28840 | SPV106 | ||
SPV106 is a ligand of lysine acetyltransferases (KATs). | |||
T12184 | Nav1.7 inhibitor | Others | Others |
Nav1.7 inhibitor is a potent inhibitor of Nav1.7. | |||
T40508 |
TRV120056
|
||
TRV120056 is a Gq-biased agonist that demonstrates a molecular efficacy ten times greater at the AT1R-Gq fusion protein than at the AT1R-βarr2 fusion protein. | |||
T79445 |
KV1.3-IN-1
|
Potassium Channel | Membrane transporter/Ion channel |
KV1.3-IN-1 (Compound trans-18) 作为KV1.3通道抑制剂,表现出对Ltk 细胞和PHA激活的T淋巴细胞的IC50值分别为230 nM和26.12 nM。该化合物干扰了细胞内Ca2+信号传导,并能够抑制T细胞的活化、增殖与集落形成。 | |||
T12183 |
Nav1.7-IN-3
|
Others | Others |
Nav1.7-IN-3 is a selective and orally bioavailable inhibitor of voltage-gated sodium channel Nav1.7(IC50 of 8 nM). | |||
TP1515 |
HPV16-E711-20 epitope
|
||
HPV16-E711-20 epitope is a well-known HLA-A*0201-restricted human cytotoxic T lymphocyte (CTL) epitope of the HPV16 E7 protein that shows high-affinity binding to HLA-A2 in vitro. | |||
T31537 |
DIV17E5
DIV17-E5,DIV17 E5,DIV-17E5,DIV 17E5 |
||
DIV17E5 is a biochemical. | |||
T61788 | TRPV1 antagonist 3 | ||
TRPV1 antagonist 3 (Compound 7q) is a highly potent antagonist of the TRPV1 receptor with an IC50 of 2.66 nM against capsaicin. It exhibits selectivity towards its mode of action and is orally bioavailable (with a bioavailability of 60%). Additionally, it can penetrate the central nervous system [1]. | |||
T38911 |
Nav1.7-IN-8
Nav1.7-IN-8 |
||
Nav1.7-IN-8 is a highly potent and selective inhibitor of NaV1.7, exhibiting greater selectivity for inhibiting NaV1.7 compared to the subtypes hNaV1.1 and hNaV1.5. Additionally, Nav1.7-IN-8 has inhibitory effects on CYP2C9 and CYP3A4, with IC50 values of 0.17 μM and 0.077 μM, respectively. Notably, Nav1.7-IN-8 demonstrates significant analgesic properties in rodent models of both acute and inflammatory pain. | |||
TP1554 |
HPV16 E7 (86-93)
|
||
This is amino acids 86 to 93 fragment of the human papilloma virus (HPV) type 16 oncoprotein E7. This HPV16-encoded peptide has very high affinity of binding to the HLA-A*0201 molecule.This immunogenic fragment may be used in vaccines for the prevention a | |||
T27757 |
Kv1.5-IN-IIII
Kv1.5INIIII,Kv1.5INIV,Compound IIII,Kv1.5IN4,Compound 4 |
||
Kv1.5-IN-IIII is a potent inhibitor of Kv1.5. | |||
T60544 |
HPV18-IN-1
|
||
HPV18-IN-1 (Compound H1) 是有效的HPV18抑制剂,可防止宫颈癌细胞的过早和异常细胞增殖。它可抑制 E7-Rb-E2F 细胞通路和 DNA 甲基化, 具有癌症研究的潜力。 | |||
T29084 |
V116517
V-116517,V 116517 |
||
V-116517, a TRPV1 antagonist, is used potentially for the treatment of severe pain due to osteoarthritis and chronic pain due postherpetic neuralgia (PHN). | |||
T63339 |
ALV1
|
||
ALV1 是 Ikaros 和 Helios 的有效降解剂,对 IKZF1/2/3 具有相似的降解活性。ALV1 可以明显减少 IKZF1-4、CK1α (酪蛋白激酶 1α,CSNK1A1) 和核糖体蛋白 RPL4 的蛋白丰度,并诱导 Helios/CRBN 二聚反应,促进了 IL-2 的分泌。 | |||
T74741 |
TRPV1 activator-1
|
||
TRPV1 activator-1 (compound 8),一种颈部结构经过改变的辣椒素类似物,特异性与T551残基相互作用。 | |||
T62422 |
Nav1.8-IN-2
|
||
Nav1.8-IN-2 (compound 35A) 是一种 Nav1.8 的有效抑制剂 (IC50: 0.4 nM)。Nav1.8-IN-2 能够用于疼痛障碍、咳嗽、急性和慢性瘙痒症的研究。 | |||
T60316 |
AV123
|
||
AV123 (化合物 12) 是一种无细胞毒性的RIPK1抑制剂,IC50值为12.12 μM。AV123 阻断 TNF-α 诱导的坏死性细胞死亡,EC50值为1.7 μM,但不阻断凋亡性细胞的死亡。AV123 可用于脑、心和肾的缺血再灌注损伤等慢性坏死性病症、炎症性疾病、神经退行性疾病和感染性疾病的研究。 | |||
T79280 |
Nav1.3 channel inhibitor 1
|
Sodium Channel | Membrane transporter/Ion channel |
Nav1.3 channel inhibitor 1 (化合物 15b) 为状态依赖性电压门控钠通道Nav1.3的抑制剂,具有IC50值为20 nM。该化合物能穿透血脑屏障,适用于神经系统疾病研究。 | |||
T74742 |
TRPV1 activator-2
|
||
TRPV1 activator-2 (compound 9)为辣椒素类似物,特异性与脂-水通道残基相互作用。 | |||
T28132 |
NaV1.7 Blocker-801
|
||
NaV1.7 Blocker-801 is a potent NaV1.7 blocker. | |||
T12179 |
Nav1.1 activator 1
|
Others | Others |
Nav1.1 activator 1 is a highly potent activator of Nav1.1 with BBB penetration. | |||
T61026 |
CaV1.3 antagonist-1
|
||
CaV1.3 antagonist-1 是一种具有帕金森病研究潜力的环戊基衍生物。CaV1.3 antagonist-1 抑制 CaV1.3 LTCC 的效率比 CaV1.2 LTCC 高 600 多倍。CaV1.3 antagonist-1 是一种有效的、高度选择性的 CaV1.3L 型钙通道拮抗剂,IC50值为 1.7 μM。 | |||
T12182 | Nav1.7-IN-2 | Others | Others |
Nav1.7-IN-2 is avoltage-gated sodium channels (Nav) inhibitor in particular Nav 1.7(IC50 of 80 nM). | |||
T76015 |
HPV16 E7 (86-93) (TFA)
|
||
HPV16 E7 (86-93) TFA,一种HLA-A2.1限制的HPV16 E7衍生肽,在宫颈癌中显示出免疫原性。 | |||
T80160 |
ω-Hexatoxin-Hv1a
ω-ACTX-Hv1,ω-Atracotoxin-HV1 |
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
ω-Hexatoxin-Hv1a,一种从毒液蜘蛛 (Hadronyche versuta) 分离得到的神经毒素,能够阻断电压门控钙通道 (calcium channels)。 | |||
T71716 |
Nav1.1-IN-B
|
||
Nav1.1-IN-B is a selective NaV1.1 inhibitor which reduces visceral hypersensitivity. | |||
T68275 |
MV151
|
||
MV151 is a fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo. MV151 specifically targets all active subunits of the proteasome and immunoproteasome in living cells, allowing for rapid and sensitive in-gel detection. The inhibition profile of a panel of commonly used proteasome inhibitors could be readily determined by MV151 labeling. Administration of MV151 to mice allowed for in vivo labeling of proteasomes, which correlated with inhibition of proteas... | |||
TP1525 |
HPV16 E7 (86-93) (TFA)(160212-93-1,free)
HPV16 E7 (86-93) (TFA) |
||
HPV16 E7 (86-93) TFA is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide. | |||
T23818 |
BPU-11
Biphenyl Urea 11 |
Others | Others |
BPU-11 (Biphenyl Urea 11) 是一种 HCN4 CLP 配体,通过调节通道功能和完全消除 cAMP 诱导的 V1/2 变化来发挥作用。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2S2215 |
Crebanine
|
Apoptosis; Others; Akt | Apoptosis; Cytoskeletal Signaling; Others; PI3K/Akt/mTOR signaling |
Crebanine 是来自于韦诺萨千金藤的一种生物碱,通过抑制 MAPKs 和 Akt 信号通路表现出抗炎活性,还具有抗心律失常的作用。它可诱导人类癌细胞的 G1阻滞和凋亡。 | |||
TN6559 |
Isogambogic acid
|
||
Isogambogic acid shows cytotoxic activiity against KB and drug-resistant KB-V1 cell lines. | |||
TN5153 |
Torilin
|
MMP; ERK; IκB/IKK; p38 MAPK; NF-κB; Tyrosinase; Reductase; DNA/RNA Synthesis; JNK | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Endocrinology/Hormones; MAPK; Metabolism; NF-κB; Proteases/Proteasome |
Torilin 是一种睾酮5α还原酶抑制剂,它(IC50=31.7+/-4.23μM)对5α还原酶的抑制作用强于α-亚麻酸(IC50=160.3+/-24.62μM),但弱于非那雄胺(IC50=0.38+/-0.06μM)。Torilin 具有免疫调节、肝脏保护和抗炎特性,它通过限制 TAK1介导的 MAP 激酶和 NF-βB 活化来抑制炎症,它可以减轻关节炎的严重程度,改变 dLN 或关节中的白细胞活化,并恢复血清和脾细胞细胞因子失衡。托利林抑制α-黑素细胞刺激激素激活的 B16黑色素瘤细胞中的黑色素生成,IC(50)值为25μM。Torilin 对枯草芽孢杆菌 ATCC 6633孢子和营养细胞表现出优异的抗菌活性。Torilin 在体内和体外都具有强大的抗血管生成活性,它可能通过抑制肿瘤侵袭来抑制肿瘤发生,逆转癌细胞的多药耐药性,它可以增强阿霉素、长春碱、紫杉醇和秋水仙碱对多药耐药 KB-V1和 MCF7/ADR 细胞的细胞毒性。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-06352 |
ALDH1A3 Protein, Mouse, Recombinant (His)
RALDH3,ALDH6,aldehyde dehydrogenase 1 family, member A3,... |
Mouse | E. coli |
ALDH1A3 Protein, Mouse, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 56.94 kDa and the accession number is Q9JHW9. | |||
TMPY-04137 |
ATP6V1F Protein, Human, Recombinant (GST)
Vma7,ATPase, H+ transporting, lysosomal 14kDa, V1 s... |
Human | E. coli |
ATP6V1F encodes a component of vacuolar ATPase mediating acidification. The cDNA and the genomic sequences of ATP6V1F were cloned successfully for the first time from the Giant Panda (Ailuropoda melanoleuca) using reverse transcription polymerase chain reaction and touchdown-polymerase chain reaction, respectively. Topology prediction showed that there is one protein kinase C phosphorylation site, two Casein kinase II phosphorylation sites, and one N-myristoylation site in the ATP6V1F protein. U... | |||
TMPY-02730 |
VNN1 Protein, Mouse, Recombinant (hFc)
V-1,vanin 1 |
Mouse | HEK293 Cells |
VNN1 Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 79 kDa and the accession number is Q9Z0K8. | |||
TMPY-02529 |
VNN1 Protein, Mouse, Recombinant (His)
vanin 1,V-1 |
Mouse | HEK293 Cells |
VNN1 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 53.4 kDa and the accession number is Q9Z0K8. | |||
TMPY-01813 |
ACRV1 Protein, Human, Recombinant (His)
SP-10,SPACA2,D11S4365,acrosomal vesicle protein 1 |
Human | HEK293 Cells |
Acrosomal protein SP-1, also known as Acrosomal vesicle protein 1 and ACRV1, is a testis-specific, differentiation antigen, that arises within the acrosomal vesicle during spermatogenesis, and is associated with the acrosomal membranes and matrix of mature sperm. Regulation of cell type-specific gene transcription is central to cellular differentiation and development. During spermatogenesis, a number of testis-specific genes are expressed in a precise spatiotemporal order. The longest tr... | |||
TMPY-00891 |
Neuropilin-1 Protein, Human, Recombinant (V179A, hFc)
neuropilin 1,VEGF165R,CD304,NP1,Neuropilin-1,NRP,BDCA4 |
Human | HEK293 Cells |
Neuropilin-1 Protein, Human, Recombinant (V179A, hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 96.5 kDa and the accession number is O14786-2. | |||
TMPJ-01100 |
UBE2V1 Protein, Human, Recombinant (His)
TRAF6-Regulated IKK Activator 1 Beta Uev1A,P/OKcl.1... |
Human | E. coli |
Ubiquitin-Conjugating Enzyme Variant 1a (UBE2V1) is a member of the Ubiquitin-conjugating (E2) enzyme family. The E2 catalytic core domain of UBE2V1 lacks an active site cysteine residue, rendering it catalytically inactive on its own. However, in the cytoplasm UBE2V1 is able to form a catalytically active complex with UBE2N/Ubc13, which mediates the synthesis Lys63-linked Ubiquitin chains and is required for NF-kappa B activation. UBE2V1 is required for UBE2N (Ubc13)/UBE2V1 Complex-dependent Ly... | |||
TMPK-01504 |
HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Tetramer Protein, Human, MHC (His & Avi)
MHC,HPV16,E7 |
Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. | |||
TMPK-01506 |
HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein, Human, MHC (His & Avi)
HPV16,E7,MHC |
Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. | |||
TMPY-06429 |
SARS-CoV-2 Spike S1+S2 Protein (P26S, 69-70 deletion & V126A & Y144 deletion & 241-243 deletion & H245Y & S477N & E484K & D614G & P681H & T1027I & D1118H, His)
|
SARS-CoV-2 | Baculovirus Insect Cells |
SARS-CoV-2 Spike S1+S2 Protein (P26S, 69-70 deletion & V126A & Y144 deletion & 241-243 deletion & H245Y & S477N & E484K & D614G & P681H & T1027I & D1118H, His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 133.72 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-04622 |
PF4V1 Protein, Human, Recombinant (mFc)
PF4A,CXCL4V1,platelet factor 4 variant 1,PF4-ALT,SC... |
Human | HEK293 Cells |
PF4V1 Protein, Human, Recombinant (mFc) is expressed in HEK293 mammalian cells with mFc tag. The predicted molecular weight is 34.6 kDa and the accession number is P10720. | |||
TMPH-03068 |
OV16 Protein, Onchocerca volvulus, Recombinant (His)
|
Onchocerca volvulus | E. coli |
OV16 Protein, Onchocerca volvulus, Recombinant (His) is expressed in E. coli. | |||
TMPK-00599 |
Fc gamma RIIIA/CD16a (V176) Domain 2 Protein, Human, Recombinant (mFc)
FCGR3,IGFR3,FcR-10,Fc γ RIIIA/CD16a (V176) Domain 2... |
Human | HEK293 Cells |
Human Fc gamma RIIIA/CD16a Protein is a receptor for the Fc region of IgG. Binds complexed or aggregated IgG and also monomeric IgG. Mediates antibody-dependent cellular cytotoxicity (ADCC) and other antibody-dependent responses, such as phagocytosis. Fc gamma RIIIA/CD16a (V176) Domain 2 Protein, Human, Recombinant (mFc) is expressed in HEK293 mammalian cells with C-mFc tag. The predicted molecular weight is 35.29 kDa and the accession number is AAH17865. | |||
TMPK-01505 |
HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein, Human, MHC (His & Avi), Biotinylated
E7,MHC,HPV16 |
Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. | |||
TMPY-06420 |
SARS-CoV-2 Spike S1 Protein (P26S & 69-70 deletion & V126A & Y144 deletion & 241-243 deletion & H245Y & S477N & E484K & D614G & P681H, His)
|
SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike S1 Protein (P26S & 69-70 deletion & V126A & Y144 deletion & 241-243 deletion & H245Y & S477N & E484K & D614G & P681H, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 75.77 kDa and the accession number is A0A6G7K2L4. | |||
TMPH-03754 |
NAV1 Protein, Human, Recombinant (His)
|
Human | E. coli |
May be involved in neuronal migration. | |||
TMPH-00140 |
IBV (strain V18/91) Nucleoprotein/NP Protein (His)
|
IBV | HEK293 Cells |
Packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. IBV (strain V18/91) Nucleoprotein/NP Protein (His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 48 kDa and the accession number... | |||
TMPY-06398 |
SARS-CoV-2 Spike S1+S2 Protein (E484K & F565L & D614G & V1176F, His)
|
SARS-CoV-2 | Baculovirus Insect Cells |
SARS-CoV-2 Spike S1+S2 Protein (E484K & F565L & D614G & V1176F, His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 134.35 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06159 |
SARS-CoV-2 Spike S1+S2 Protein (L18F & T20N & P26S & D138Y & R190S & K417T & E484K & N501Y & D614G & H655Y & T1027I & V1176F, His)
|
SARS-CoV-2 | Baculovirus Insect Cells |
SARS-CoV-2 Spike S1+S2 Protein (L18F & T20N & P26S & D138Y & R190S & K417T & E484K & N501Y & D614G & H655Y & T1027I & V1176F, His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 134.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPH-02035 |
ASPRV1 Protein, Human, Recombinant (His & Myc)
Retroviral-like aspartic protease 1,TAPS,Skin aspartic prote... |
Human | E. coli |
ASPRV1 Protein, Human, Recombinant (His & Myc) is expressed in in vitro E. coli expression system. | |||
TMPJ-00849 |
ST2/IL-1 RL1 Protein, Mouse, Recombinant (V192A, hFc)
Protein ST2,IL-1 R4,IL-33R,ST2V,suppression of tumorigenicit... |
Mouse | HEK293 Cells |
ST2/IL-1 RL1 Protein, Mouse, Recombinant (V192A, hFc) is expressed in HEK293 mammalian cells with C-Fc tag. The predicted molecular weight is 90-110 KDa and the accession number is P14719-2. | |||
TMPK-00597 |
Fc gamma RIIIA/CD16a (V176) Protein, Human, Recombinant (His & Avi)
CD16,FcRIII,IMD20,IGFR3,FCG3,Fc γ RIIIA,CD16A,FCGR3,FcRIIIa,... |
Human | HEK293 Cells |
Human Fc gamma RIIIA/CD16a Protein is a receptor for the Fc region of IgG. Binds complexed or aggregated IgG and also monomeric IgG. Mediates antibody-dependent cellular cytotoxicity (ADCC) and other antibody-dependent responses, such as phagocytosis. Fc gamma RIIIA/CD16a (V176) Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 24.7 kDa and the accession number is AAH17865. | |||
TMPK-00598 |
Fc gamma RIIIA/CD16a (V176) Protein, Human, Recombinant (His & Avi), Biotinylated
Fc gamma RIIIA,Fc γ RIIIA,FCGR3,FcRIII,FCG3,IGFR3,FCGR3A,FcR... |
Human | HEK293 Cells |
The Human Fc gamma RIIIA/CD16a Protein is a receptor for the Fc region of IgG. Binds complexed or aggregated IgG and also monomeric IgG. Mediates antibody-dependent cellular cytotoxicity (ADCC) and other antibody-dependent responses, such as phagocytosis. | |||
TMPH-02718 |
Igkv12-41 Protein, Mouse, Recombinant (His & Myc)
|
Mouse | E. coli |
Igkv12-41 Protein, Mouse, Recombinant (His & Myc) is expressed in E. coli. | |||
TMPY-06399 |
SARS-CoV-2 Spike S1 Protein (E484K & F565L & D614G & V1176F, His)
|
SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike S1 Protein (E484K & F565L & D614G & V1176F, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 76.37 kDa and the accession number is A0A6G7K2L4. |